Cardax (Cardax) Short Interest

View and export this data going back to 2012. Start your Free Trial

What is Cardax Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Cardax's Short Interest

For the Biotechnology subindustry, Cardax's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cardax's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cardax's Short Interest distribution charts can be found below:

* The bar in red indicates where Cardax's Short Interest falls into.

Cardax (Cardax) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cardax Inc (OTCPK:CDXI) » Definitions » Short Interest

Comparable Companies

IMUN BOM:506365 PPCB HSTC XCNQ:NSHS RSPI BOM:542910 BOM:539206 RBSH GNBT

Traded in Other Exchanges

N/A

Address

2800 Woodlawn Drive, Suite 129, Honolulu, HI, USA, 96822

Website

http://www.cardaxpharma.com

Cardax Inc is a life sciences company engaged in the development of marketing, and distribution of consumer health products in the United States. The firm's platform has applications in arthritis, metabolic syndrome, liver disease, and cardiovascular disease, as well as macular degeneration and prostate disease. It is focused on the development of astaxanthin technologies. The group's product ZanthoSyn is marketed as a novel astaxanthin dietary supplement. Astaxanthin is a clinically studied ingredient with a safe anti-inflammatory activity that supports joint health, cardiovascular health, metabolic health, and liver health. Geographically, it generates maximum revenue from the United States.

Executives

Paulson Capital Corp	10 percent owner	222 THIRD STREET, SUITE 2241, CAMBRIDGE MA 02142
Paulson Investment Company, Inc.	10 percent owner	5335 MEADOWS ROAD SUITE 465 LAKE OSWEGO OR 97035
Paulson Cardax Investments 1 Llc	10 percent owner	811 SW NAITO PKWY SUITE 300 PORTLAND OR 97204